Stéphane Bancel
斯特凡纳·班塞尔
MS (Chemical Engineering), MBA
Chief Executive Officer, Moderna, Inc.Moderna公司首席执行官
👥Biography 个人简介
Stéphane Bancel is CEO of Moderna, the company he has led since 2011 from startup to global mRNA medicine pioneer. Under his leadership, Moderna developed mRNA-1273 (Spikevax) and advanced mRNA-4157/V940 (individualized neoantigen cancer vaccine) into pivotal phase 3 trials in melanoma, NSCLC, and other cancers. He has championed mRNA as a transformative oncology platform.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Scaling mRNA Manufacturing for Cancer Vaccines
Built Moderna's proprietary mRNA manufacturing and lipid nanoparticle formulation infrastructure, enabling rapid production of individually encoded neoantigen vaccines within weeks of tumor sequencing, a prerequisite for personalized cancer vaccine commercialization.
KEYNOTE-942 Pivotal Program and Regulatory Strategy
Drove the strategic Merck partnership (2016) and KEYNOTE-942 phase 2b/3 program for mRNA-4157/V940, leading to FDA Breakthrough Therapy Designation and the launch of phase 3 randomized trials across multiple tumor types.
mRNA Platform Expansion into Oncology
Expanded Moderna's pipeline to include not only individualized cancer vaccines but also intratumoral IL-2 mRNA, KRAS-targeted mRNA vaccines (mRNA-5671), and cancer immunotherapy combinations, establishing a diversified mRNA oncology portfolio.
Representative Works 代表性著作
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
New England Journal of Medicine (2021)
Phase 3 COVE trial demonstrating 94.1% vaccine efficacy for mRNA-1273; established the industrial and regulatory credibility of Moderna's mRNA-LNP platform for broader clinical application including cancer vaccines.
mRNA-4157 (V940) plus pembrolizumab vs pembrolizumab alone in resected high-risk melanoma (KEYNOTE-942)
The Lancet (2023)
Phase 2b results demonstrating 44% reduction in recurrence/death with mRNA-4157 + pembrolizumab, the first randomized evidence that a personalized mRNA cancer vaccine improves clinical outcomes.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
关注 斯特凡纳·班塞尔 的研究动态
Follow Stéphane Bancel's research updates
留下邮箱，当我们发布与 Stéphane Bancel（Moderna, Inc.）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment